IP Verse

Amgen vs. Regeneron Pharmaceuticals - ACT_459916/2023

The case ACT_459916/2023 was filed by the plaintiff Amgen Inc. against the defendant Regeneron Pharmaceuticals Inc., Sanofi-Aventis Deutschland Gmbh on 26 Jun, 2023. The case decision was made on Feb 2, 2024.

Case Timeline

26 Jun, 2023
Case Filed
Feb 2, 2024
Decision

Case Details

    Case Number:

    ACT_459916/2023

    Patent Number:

    EP3666797

    Filing Date:

    26 Jun, 2023

    Proceeding Type:

    Proceeding

    Action/Application:

    Infringement Action

    Plaintiffs:

    • Amgen Inc.

    Plaintiff Representative:

    • Johannes Heselberger

    Defendants:

    • Regeneron Pharmaceuticals Inc.
    • Sanofi-Aventis Deutschland Gmbh
    • Sanofi-Aventis Groupe S.A.
    • Sanofi Winthrop Industrie S.A.

    Defendant Representative:

    • Niels Hoelder

    Judges:

    • Matthias Zigann
    • Samuel Granata
    • Tobias Pichlmaier
    • Xavier DORLAND-GALLIOT

    Court Division:

    First Instance, Local Division - Munich

Case Decision

    Decision Date:

    Feb 2, 2024

    Decision Document:

    View document

More cases involving EP3666797B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_3214/2025Jan 21, 2025Redacted Natural Person NameAmgen, Dehns, Redacted Natural Person Name, Sanofi Aventis Deutschland, Sanofi Aventis Groupe, Sanofi Winthrop Industrie
APL_51679/2024Sep 13, 2024AmgenSanofi Aventis Deutschland, Sanofi Aventis Groupe, Sanofi Winthrop Industrie
APL_51683/2024Sep 13, 2024AmgenRegeneron Pharmaceuticals

More cases involving Amgen

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_35200/2025Aug 21, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
APP_35086/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
APP_35087/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -

More cases involving Regeneron Pharmaceuticals

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_34318/2025Aug 5, 2025Regeneron Pharmaceuticals -
ORD_34329/2025Aug 5, 2025AmgenRegeneron Pharmaceuticals
APP_33251/2025Jul 21, 2025Regeneron Pharmaceuticals -